Company: RCUS
Filing Date: 2025-08-06
Form Type: 10-Q
Source: 0001724521-25-000101
Chunk: 192

Company: Arcus Biosciences, Inc.
Filing Date: 2025-08-06
Form: 10-Q
Item: Part II, Item 5
Chunk 192
---
Item 5. Other Information.

Rule 10b5-1 Trading Arrangements

The adoption, modification or termination of contracts, instructions or written plans for the purchase or sale of our securities by our Section 16 officers and directors for the three months ended June 30, 2025, which are intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act, were as follows:Name and TitleActionDateTotal Shares to be SoldExpiration DateAlex AzoyChief Accounting OfficerAdoptionJune 6, 202528,022June 4, 2026Jennifer JarrettChief Operating OfficerAdoptionJune 30, 2025100,583April 10, 2026

64